Charles Douglas McDermott's Net Worth

$0

Estimate Recalculated Nov 1, 2024 06:31AM EST

Who is Charles Douglas McDermott?

Charles Douglas McDermott does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Equillium, Inc., and Kala Pharmaceuticals, Inc..

SEC CIK

Charles Douglas McDermott's CIK is 0001710696

Past Insider Trading and Trends

2020 was Charles Douglas McDermott's most active year for acquiring shares with 2 total transactions. Charles Douglas McDermott's most active month to acquire stocks was the month of April. 2020 saw Charles Douglas McDermott paying a total of $0.00 for 43,916 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Equillium, Inc. (EQ) Snapshot price: $1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Jun 11
Form 3
—
0
—
—
0
No matching records found

Kala Pharmaceuticals, Inc. (KALA) Snapshot price: $6.1

President and Chief Bus. Off.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found